We are actively studying the relationship between M. tuberculosis pathogenesis and the chemical structure of the mycobacterial cell envelope.
The Mtb cell envelope differs substantially from the cell walls of gram-positive and gram-negative bacteria and contains many unique lipid and glycolipid molecules, including mycolic acids, Lipoarabinomannan, Trehalose Dimycolate, and Phthiocerol dimycocerosate. While the structures of many of these molecules have been defined in exquisite chemical detail, their role in pathogenesis has been unclear.
To understand the role of these unique chemical entities in pathogenesis, we and others have generated defined mutants of Mtb that lack specific compounds in the cell envelope. We have focused on a family of S-adenosyl Methionine dependent methyltransfersase of Mtb that modify mycolic acids with cyclopropyl groups. By studying null mutants in each methyltransferase, we have shown that site specific and stereochemically specific mycolic acid cyclopropanation has an important role in Mtb pathogenesis. In addition, we have recently demonstrated that cyclopropanation of mycolic acids on Trehalose Dimycolate acts directly to activate (cis cyclopropanation) or repress (trans-cyclopropanation) host innate immune activation. These results establish cyclopropane modification of TDM as a direct effector of pathogenesis. More generally, these result support the emerging view that the mycobacterial cell envelope is a complex array of lipid pathogenesis determinants rather than a waxy coat that serves a simple barrier function.
Our immediate future experimental goals will address the following questions: